Simon Tarsh
CIK 1943931 · Interim CFO · last filed 2025-08-19
Simon Tarsh is an Interim CFO who has filed 6 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for ONCO, was dated Aug 19, 2025. Current disclosed insider exposure totals $41 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$41
3
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ONCO | Director | 40 | $1.02 | $41 | $0 | 2 | 2025-08-19 |
| RENOVARO INC. (RENB) Delisted | Interim CFO | — | $1.54 | — | $0 | 2 | 2024-11-06 |
| Onconetix, Inc. (BWV) Delisted | Director | 6,360 | $0.18 | $1.1K | $0 | 2 | 2023-06-01 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-19 | ONCO | Mixed | +657 | $0 | EDGAR |
| 2024-11-06 | RENOVARO INC. (RENB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-09-30 | ONCO | Grant (A) | +3,318 | $0 | EDGAR |
| 2024-03-13 | RENOVARO INC. (RENB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-01 | Onconetix, Inc. (BWV) Delisted | Grant (A) | +6,360 | $0 | EDGAR |
| 2022-08-24 | Onconetix, Inc. (BWV) Delisted | Grant (A) | — | $0 | EDGAR |